rhodopsin R135W gene therapy (Beijing Chinagene Technology)

N/A

Report date: 2025/01/26 19:35:18

Base Information

Drug Namerhodopsin R135W gene therapy (Beijing Chinagene Technology)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionRhodopsin modulators
TargetsRhodopsin
Therapy Area/IndicationsRetinal Dysplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesChigenovo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChigenovo Co Ltd
Inactive CompaniesN/A
Active IndicationsRetinal Dysplasia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A